HHLR Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$819K Hold
62,176
– – 0.1% 31
2026
Q1
$1.63M Hold
62,176
– – 0.1% 23
2025
Q4
$15.4M Hold
62,176
– – 0.5% 14
2025
Q3
$13.1M Hold
62,176
– – 0.32% 17
2025
Q2
$6.12M Hold
62,176
– – 0.2% 21
2025
Q1
$5.47M Hold
62,176
– – 0.15% 25
2024
Q4
$4.5M Hold
62,176
– – 0.16% 24
2024
Q3
$4.91M Hold
62,176
– – 0.11% 24
2024
Q2
$4.48M Hold
62,176
– – 0.11% 40
2024
Q1
$5.87M Hold
62,176
– – 0.13% 36
2023
Q4
$4.54M Hold
62,176
– – 0.09% 34
2023
Q3
$4.14M Hold
62,176
– – 0.09% 44
2023
Q2
$5.97M Hold
62,176
– – 0.13% 42
2023
Q1
$6.27M Hold
62,176
– – 0.11% 49
2022
Q4
$10.8M Sell
62,176
-30,586
-33% -$20.1M 0.23% 39
2022
Q3
$88.9M Hold
92,762
– – 2.34% 13
2022
Q2
$62.1M Hold
92,762
– – 1.33% 19
2022
Q1
$64.4M Hold
92,762
– – 1.34% 15
2021
Q4
$83.9M Hold
92,762
– – 1.3% 17
2021
Q3
$93.3M Hold
92,762
– – 1.22% 18
2021
Q2
$60.3M Hold
92,762
– – 0.62% 26
2021
Q1
$68.6M Hold
92,762
– – 0.68% 25
2020
Q4
$71.8M Hold
92,762
– – 0.57% 27
2020
Q3
$92.1M Hold
92,762
– – 0.7% 25
2020
Q2
$96.5M Buy
92,762
+18,868
+26% +$19M 0.88% 24
2020
Q1
$60M Hold
73,894
– – 0.81% 23
2019
Q4
$92.4M Hold
73,894
– – 1.15% 20
2019
Q3
$99.3M Buy
73,894
+62,175
+531% +$98.9M 1.36% 19
2019
Q2
$20.8M Hold
11,719
– – 0.47% 29
2019
Q1
$20.3M Buy
+11,719
New +$19.6M 0.57% 22

Other funds holding GOSS

HHLR Advisors's GOSS Position: Q2 2026 in Review

HHLR Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 62,176 shares worth $819K. The position accounts for 0.1% of the portfolio, ranked #31.

HHLR Advisors first reported a position in GOSS in Q1 2019 and has held it in 30 quarters since. The position peaked at $99.3M in Q3 2019. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • HHLR Advisors held 62,176 shares of Gossamer Bio worth $819K as of Q2 2026.
  • HHLR Advisors left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up 0.1% of HHLR Advisors's portfolio in Q2 2026, its #31 holding.
  • HHLR Advisors first reported a position in Gossamer Bio in Q1 2019 and has held it in 30 quarters since.
  • HHLR Advisors's Gossamer Bio position peaked at $99.3M in Q3 2019.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on HHLR Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.